Episode 104
What’s Next in Medtech Matters to Us All
Medtech is a $900 billion industry transforming how we treat, diagnose, and prevent disease—but its innovation engine is slowing. Vikram Aggarwal, global leader of BCG’s medical technology work, explains what’s behind the slowdown and how leaders can rethink regulation, software, and talent to re-accelerate breakthroughs.
Learn More:
Vikram Aggarwal: https://on.bcg.com/4osjpc6
BCG on Medtech: https://on.bcg.com/3LlJ6MC
How Medtech Leaders Are Revving Up Their Innovation Engines: https://on.bcg.com/4op2Rl8
Chapters
00:00-01:25 Introduction/Vikram’s ‘So What’
02:11-03:46 Where are some of the most exciting innovations happening in medtech?
03:47-05:36 What areas get the most attention?
05:37-07:33 What are the barriers to innovation?
07:34-08:36 How do software and hardware innovation compare?
08:37-09:58 Software in a medical device vs software as a medical device
09:59-11:40 Is there a lag between innovation in software vs hardware?
11:41-13:41 What is the ideal innovation environment for medtech?
13:42-15:13 How do we fix the STEM skills shortage?
15:14-17:46 What will bring the most value over the next decade?
17:47-19:04 What is happening at startups vs established companies?
19:05 – 20:01 Vikram’s ‘Now What’
This podcast uses the following third-party services for analysis:
Podtrac - https://analytics.podtrac.com/privacy-policy-gdrp
